Man Group
IRWD icon

Man Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Man Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
540,864
+493,205
+1,035% +$2.02M ﹤0.01% 1596
2025
Q4 		$161K Buy
+47,659
New +$124K ﹤0.01% 2158
2025
Q3 		– Sell
-234,257
Closed -$168K – 2338
2025
Q2 		$168K Sell
234,257
-99,461
-30% -$78.1K ﹤0.01% 2095
2025
Q1 		$491K Sell
333,718
-21,106
-6% -$50.3K ﹤0.01% 1801
2024
Q4 		$1.57M Sell
354,824
-539,902
-60% -$2.19M ﹤0.01% 1383
2024
Q3 		$3.69M Sell
894,726
-2,089,725
-70% -$11.2M 0.01% 1128
2024
Q2 		$19.5M Sell
2,984,451
-862
-0% -$6.1K 0.05% 448
2024
Q1 		$26M Buy
2,985,313
+1,559,924
+109% +$18.9M 0.07% 338
2023
Q4 		$16.3M Buy
+1,425,389
New +$14.1M 0.05% 471
2023
Q3 		– Sell
-2,976,050
Closed -$29.2M – 296
2023
Q2 		$31.7M Buy
+2,976,050
New +$32M 0.1% 252
2023
Q1 		– Sell
-1,384,470
Closed -$15.5M – 436
2022
Q4 		$17.2M Buy
1,384,470
+546,193
+65% +$6.2M 0.06% 386
2022
Q3 		$8.68M Buy
+838,277
New +$9.5M 0.04% 519
2022
Q2 		– Sell
-216,309
Closed -$2.55M – 1076
2022
Q1 		$2.72M Sell
216,309
-66,685
-24% -$764K 0.01% 1120
2021
Q4 		$3.3M Sell
282,994
-16,489
-6% -$202K 0.01% 1023
2021
Q3 		$3.91M Sell
299,483
-95,551
-24% -$1.23M 0.01% 941
2021
Q2 		$5.08M Buy
395,034
+208,808
+112% +$2.39M 0.02% 877
2021
Q1 		$2.08M Sell
186,226
-1,531,745
-89% -$16.2M 0.01% 1091
2020
Q4 		$19.6M Sell
1,717,971
-307,697
-15% -$3.37M 0.09% 228
2020
Q3 		$18.2M Buy
2,025,668
+1,154,168
+132% +$11.5M 0.07% 293
2020
Q2 		$8.99M Buy
871,500
+79,637
+10% +$815K 0.05% 394
2020
Q1 		$7.99M Buy
791,863
+621,395
+365% +$7.3M 0.05% 355
2019
Q4 		$2.27M Buy
+170,468
New +$1.88M 0.01% 1295
2019
Q2 		– Sell
-107,015
Closed -$1.21M – 1940
2019
Q1 		$1.21M Buy
107,015
+64,063
+149% +$715K ﹤0.01% 1524
2018
Q4 		$373K Sell
42,952
-109,285
-72% -$1.25M ﹤0.01% 1684
2018
Q3 		$2.35M Buy
+152,237
New +$2.41M 0.01% 1357

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Man Group's IRWD Position: Q1 2026 in Review

Man Group increased its Ironwood Pharmaceuticals (IRWD) stake by 1,035% in Q1 2026, buying an estimated $2.02M and bringing the position to 540,864 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Man Group first reported a position in IRWD in Q3 2018 and has held it in 25 quarters since. The position peaked at $31.7M in Q2 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Man Group held 540,864 shares of Ironwood Pharmaceuticals worth $1.9M as of Q1 2026.
  • Man Group bought 493,205 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $2.02M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1596 holding.
  • Man Group first reported a position in Ironwood Pharmaceuticals in Q3 2018 and has held it in 25 quarters since.
  • Man Group's Ironwood Pharmaceuticals position peaked at $31.7M in Q2 2023.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.